Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder



Get the latest updates from STAT directly as they happen.

Follow now 92 followers

Latest posts

Last updated about 2 hours ago

Antibody drugs appear effective. Now can we make enough of them?

about 2 hours ago

The Covid-19 pandemic teaches one lesson, over and over: The virus is...

Opinion: Lessons for monitoring Covid-19 vaccine safety from the H1N1 pandemic

about 2 hours ago

As the country and the world eagerly await vaccines to curb the...

Opinion: Laws to ban gender-affirming care could increase youth suicides, parents fear

about 2 hours ago

Legislation proposed or under consideration in 19 states since early 2020 aims...

Is it safe to lick the ballot envelope? Public health officials take on the new challenge of making voting safe amid a pandemic

about 2 hours ago

In their efforts to stem the spread of the coronavirus, public health...

It may be time to reset expectations on when we’ll get a Covid-19 vaccine

about 3 hours ago

The ambitious drive to produce Covid-19 vaccine at warp speed seems to...

A MacArthur ‘genius’ will likely use his grant to support his wife’s work — in the name of science

about 3 hours ago

There’s a rare and touching symbiosis in Damien Fair’s marriage. The prominent...

STAT+: Startup Spotlight: Encoded eyes a gene therapy for Dravet syndrome

about 18 hours ago

Kartik Ramamoorthi started the gene therapy company Encoded in an unusual way...

STAT+: Google and the Mayo Clinic to use AI to better target radiation therapy

about 18 hours ago

In the first project of their sweeping data partnership, Google and the...

STAT+: Pharmalittle: Lilly signs $375 million deal with U.S. for Covid-19 drug; Sanofi and Glaxo will supply vaccine to COVAX

about 22 hours ago

Good morning, everyone, and welcome to the middle of the week. Congratulations...

Opinion: There’s a silent crisis in clinical research. And it’s not Covid-19

1 day ago

The pharmaceutical industry is racing in unprecedented ways to develop therapies to...

Opinion: There’s no place like home for older and high-risk people to get Covid-19 vaccines

1 day ago

Staying at home has never been so vital for older Americans and...

In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’

1 day ago

WASHINGTON — Even in an election year dominated by a deadly pandemic...